期刊文献+

比索洛尔对缺氧/复氧内皮细胞一氧化氮生成的影响 被引量:2

Effects of Bisoprolol on nitric oxide production by endothelial cells during anoxia/reoxygenation
暂未订购
导出
摘要 目的 :观察比索洛尔对培养的人脐静脉内皮细胞 (HU VECs)在缺氧 /复氧 (A/ R)过程中一氧化氮 (NO)生成的影响。方法 :将 HUVECs暴露于缺氧环境中 30 m in后复氧 ,并加入比索洛尔 (1,5 0和 5 0 0 μmol/ L)或空白对照 ,测量复氧前、复氧后 1和 4h培养液上清 NO含量。结果 :对照组 NO产量在复氧后 1h,4h与复氧前相比有显著下降 (均 P<0 .0 1)。比索洛尔 5 0 μm ol/ L 组和 5 0 0 μmol/ L 组 NO产量在复氧后 1h,4h与复氧前相比无显著差异 (均P>0 .0 5 ) ,而与对照组和 1μmol/ L 组同一时间相比均有显著增加 (均 P<0 .0 1)。结论 :比索洛尔可以阻止 A/ R期间内皮细胞 NO产量的下降 ,因此 NO可能参与了 β阻滞剂减少缺血再灌注损伤的过程。 AIM: To investigate the effects of bisoprolol on nitric oxide (NO) production by cultured human umbilical vein endothelium cells(HUVECs) during anoxia/reoxygenation(A/R). METHODS:After 30 min period of anoxia by exposing HUVECs monolayers to a chamber filled with 100% N 2,reoxygenation was initiated, and meanwhile Bisoprolol (1,50,500 μmol/L or control) was added to HUVECs monolayers. Products of NO in HUVECs supernatants were determined 0,1 and 4h after reoxygenation. RESULTS:In control group, level of products of NO decreased significantly 1 h ( P <0.01) and 4 h ( P <0.01) after reoxygenation. Adding of 50 μmol/L or 500 μmol/L Bisoprolol resulted in maintaining of NO products ( P >0.05),and comparing to control and 1 μmol/L Bisoprolol group level of products of NO increased significantly in 50 μmol/L and 500 μmol/L Bisoprolol group 1, 4 h after reoxygenation ( P <0.01). CONCLUSION:Bisoprolol can prevent level of endothelium derived NO from decreasing during A/R, so NO may play a role in the mechanism by which β blockers can reduce ishemic reperfusion injury.
出处 《心脏杂志》 CAS 2001年第2期93-94,97,共3页 Chinese Heart Journal
关键词 比索洛尔 缺氧 复氧 内皮 一氧化氮 bisoprolol anoxia/reoxygenation endothelium nitric oxide
  • 相关文献

参考文献8

  • 1[1]Khaper N, Rigatto C, Seneviratne C,et al. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury[J]. J Mol Cell Cardiol,1997, 29(12):3335.
  • 2[2]Zmudka K, Dubiel J, Vanhaecke J, et al. Effects of oral pretreatment with metoprolol on left ventricular wall motion,infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion[J]. Cardiovasc Drugs Ther, 1994, 8(3):479.
  • 3[3]Jordan JE, Zhao ZQ, Vinten-Johansen J, et al. The role of neutrophils in myocardial ischemia-reperfusion injury[J]. Cardiovasc Res, 1999, 43(4):860.
  • 4[4]Inauen W,Granger DN,Meininger CJ, et al.An in vitro model of ischemia/reperfusion-induced microvascular injury[J]. Am J Physiol,1990,259:G134.
  • 5[5]Roth E, Matos G, Guarnieri C, et al. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow[J]. Acta Physiol Hung, 1995,83(2):163.
  • 6[6]Sobey CG, Dalipram RA, Dusting GJ, et al. Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol[J]. Br J Pharmacol, 1992,105(3):557.
  • 7[7]Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion[J]. Cardiovasc Res, 1996,32(4):743.
  • 8[8]Mehta JL,Lopez LM,Cox OE, et al. Alterations in nitric oxide synthase activity,superoxide anion generation,and platelet aggregation in systemic hypertension,and effects of celiprolol[J]. Am J Cardiol, 1994,74:901.

同被引文献12

  • 1虞准,田小园,彭晓玲,王涓,吴扬慧,夏志崎,廖志勇.卡维地洛对老年不稳定型心绞痛患者的疗效观察[J].热带医学杂志,2006,6(7):819-820. 被引量:2
  • 2MERI-HF Study Group.Effect of metoprolol CR/XL in chronic heart failure.Metoprolol CR/XL Randomized Intention Trial in Congertive Heart Failure (MERI-HF)[J].Lancet,1999,353(9169):2001-2007.
  • 3EUGENE B,ELLIOTT V I,JOHN W,et al.ACC/AHA guidelines for the management of patients with unstable angina and non -ST -segment elevation myocardial infarction:Executive Summary and Recommendations[J].Circulation,2000,102:1193-1209.
  • 4YOSHIKAWA T,PORT J D,ASANO K,et al.Cardiac adrenergic receptor effect of carvedilol[J].Eur Heart J,1996,17(supplB):8-9.
  • 5PACKER M.The effect of carvedilon morbidity and mortality in patients with chronic heart failure[J].N Engl J Med,1996,334:1349-1355.
  • 6ROTH E,MATOS G,GUARNIERI C,et al.Influence of the betablocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow[J].Acta Physiol Hung,1995,83:163-164.
  • 7DARGIE H J.Effect of carvedilol on outcom after myocardial infarction in patients with left-ventricular dysfunction:the CAPRICORN randomised trial[J].Lancet,2001,357 (9266):1385-1390.
  • 8Jung BF,Johnson RW,Griffn DRJ,et al.Risk factors forpostherpetic neuralgia in patients with herpes zoster[].Neurology.2004
  • 9廖伟,高丽丽.卡维地洛治疗老年不稳定型心绞痛的疗效和安全性评价[J].中国老年学杂志,2011,31(11):2082-2083. 被引量:14
  • 10徐蓉,邱凌,汪思阳,曲毅.丹参多酚酸盐治疗老年不稳定型心绞痛患者的临床疗效评价[J].中国老年学杂志,2011,31(23):4672-4673. 被引量:17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部